Antithymocyte Globulin for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation

被引：10
|
作者：
Mohty, Mohamad [1 ]
Malard, Florent
机构：
[1] Hop St Antoine, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 36期
关键词：
MATCHED UNRELATED DONORS; ANTI-THYMOCYTE GLOBULIN; OPEN-LABEL; HEMATOLOGICAL MALIGNANCIES; PHASE-3; TRIAL; MULTICENTER; MARROW; PREVENTION; MORTALITY; OUTCOMES;
D O I：
10.1200/JCO.2017.76.0512
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：3993 / +
页数：4
相关论文
共 50 条
  • [21] Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    WU Xiao-long
    ZHUANG Hai-feng
    ZHAO Yan-na
    YU Xiao-ling
    DAI Tie-ying
    GAO Rui-lan
    Chinese Journal of Integrative Medicine, 2020, 26 (05) : 324 - 329
  • [22] Bortezomib for the prevention and treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Al-Homsi, Ahmad Samer
    Feng, Yuxin
    Duffner, Ulrich
    Al Malki, Monzr M.
    Goodyke, Austin
    Cole, Kelli
    Muilenburg, Marlee
    Abdel-Mageed, Aly
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (09) : 771 - 777
  • [23] Biological advances in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Duran-Struuck, Raimon
    Reddy, Pavan
    TRANSPLANTATION, 2008, 85 (03) : 303 - 308
  • [24] Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Xiao-long Wu
    Hai-feng Zhuang
    Yan-na Zhao
    Xiao-ling Yu
    Tie-ying Dai
    Rui-lan Gao
    Chinese Journal of Integrative Medicine, 2020, 26 : 324 - 329
  • [25] The effect of costimulatory moleculars on graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Qiao, Zhenhua
    Ye, Fang
    Zu, Lei
    BLOOD, 2007, 110 (11) : 293B - 294B
  • [26] Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    WU Xiao-long
    ZHUANG Hai-feng
    ZHAO Yan-na
    YU Xiao-ling
    DAI Tie-ying
    GAO Rui-lan
    Chinese Journal of Integrative Medicine, 2020, (05) : 324 - 329
  • [27] Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Wu Xiao-long
    Zhuang Hai-feng
    Zhao Yan-na
    Yu Xiao-ling
    Dai Tie-ying
    Gao Rui-lan
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2020, 26 (05) : 324 - 329
  • [28] Onset of Ocular Graft-Versus-Host Disease Symptoms After Allogeneic Hematopoietic Stem Cell Transplantation
    Shikari, Hasanain
    Amparo, Francisco
    Saboo, Ujwala
    Dana, Reza
    CORNEA, 2015, 34 (03) : 243 - 247
  • [29] Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Tanaka, John
    Young, Rebecca
    Heston, Sarah M.
    Jenkins, Kirsten
    Spees, Lisa
    Sung, Anthony D.
    Corbet, Kelly
    Thompson, Jillian C.
    Bohannon, Lauren
    Martin, Paul L.
    Stokhuyzen, Andre
    Vinesett, Richard
    Ward, Doyle, V
    Bhattarai, Shakti K.
    Bucci, Vanni
    Arshad, Mehreen
    Seed, Patrick C.
    Kelly, Matthew S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (11) : 2053 - 2060
  • [30] Anaerobic Antibiotics and the Risk of Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Tanaka, John
    Young, Rebecca
    Spees, Lisa
    Jenkins, Kirsten
    Sung, Anthony D.
    Martin, Paul L.
    Heston, Sarah
    Thompson, Jillian C.
    Seed, Patrick
    Arshad, Mehreen
    Kelly, Matthew
    BLOOD, 2019, 134
12345